POSTER 57

Integrated Interval Analysis of Clinical Trial Data to Evaluate the Long-Term Safety of Risankizumab in Patients With Psoriatic Disease

Kenneth B Gordon, Andrew Blauvelt, Hervé Bachelez, Laura C Coates, Filip E Van den Bosch, Blair Kaplan, Willem Koetse, Ralph Lippe, Doug G Ashley, Kim A Papp

< Previous Poster | Next Poster >

Poster 57